BrightSpring Health Services Inc
For the period ended Sep 30, 2024. Filed Nov 1, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 1, 2024
BTSG$72.49+4.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
| For the Nine Months Ended | ||
|---|---|---|
| September 30, | ||
| 2024 | 2023 | |
| Operating activities: | ||
| Net loss | $(35,925) | $(149,634) |
| Adjustments to reconcile net loss to cash (used in) provided by operating activities: | ||
| Depreciation and amortization | 149,601 | 151,324 |
| Impairment of long-lived assets | 4,781 | 8,295 |
| Provision for credit losses | 21,896 | 18,927 |
| Amortization of deferred debt issuance costs | 9,477 | 15,691 |
| Share-based compensation | 55,194 | 2,100 |
| Deferred income taxes, net | (27,781) | (36,565) |
| Loss on extinguishment of debt | 12,726 | — |
| (Gain) loss on disposition of fixed assets | (55) | 957 |
| Other | (959) | (210) |
| Change in operating assets and liabilities, net of acquisitions and dispositions: | ||
| Accounts receivable | (163,996) | (116,922) |
| Prepaid expenses and other current assets | (2,470) | (162) |
| Inventories | (74,265) | 53,244 |
| Trade accounts payable | 155,563 | (58,313) |
| Accrued expenses | (150,032) | 159,353 |
| Other assets and liabilities | (20,593) | 298 |
| Net cash (used in) provided by operating activities | $(66,838) | $48,383 |
| Investing activities: | ||
| Purchases of property and equipment | $(65,602) | $(56,693) |
| Acquisitions of businesses, net of cash acquired | (59,755) | (62,508) |
| Other | 900 | 1,790 |
| Net cash used in investing activities | $(124,457) | $(117,411) |
| Financing activities: | ||
| Long-term debt borrowings | $2,566,000 | $— |
| Long-term debt repayments | (3,384,633) | (22,857) |
| Proceeds from issuance of common stock on initial public offering, net | 656,485 | — |
| Proceeds from issuance of tangible equity units, net | 389,000 | — |
| Borrowings of the Revolving Credit Facility, net | 46,400 | 98,250 |
| Payment of debt issuance costs | (43,188) | — |
| Repurchase of shares of common stock | (650) | (325) |
| Shares issued under share-based compensation plan, including tax effects | 531 | 598 |
| Payment of acquisition earn-outs | (4,156) | — |
| Purchase of redeemable noncontrolling interest | (2,316) | — |
| Payment of financing lease obligations | (9,276) | (8,625) |
| Net cash provided by financing activities | $214,197 | $67,041 |
| Net increase (decrease) in cash and cash equivalents | 22,902 | (1,987) |
| Cash and cash equivalents at beginning of year | 13,071 | 13,628 |
| Cash and cash equivalents at end of year | $35,973 | $11,641 |
Condensed Consolidated Statements of Cash Flows (continued)
| For the Nine Months Ended | ||
|---|---|---|
| September 30, | ||
| 2024 | 2023 | |
| Supplemental disclosures of cash flow information: | ||
| Cash paid for: | ||
| Interest, net | $164,927 | $225,893 |
| Income taxes, net of refunds | $24,312 | $35,640 |
| Supplemental schedule of non-cash investing and financing activities: | ||
| Notes issued and contingent liabilities assumed in connection with acquisitions | $23,408 | $7,455 |
| Financing lease obligations | $9,625 | $8,586 |
| Repurchases of common stock in accounts payable | $— | $975 |
| Purchases of property and equipment in accounts payable | $3,593 | $9,870 |
| Consideration for purchase of redeemable noncontrolling interest in accounts payable | $5,100 | $— |
| Shares issued in connection with acquisitions | $31,081 | $— |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.